1997Journal of NeurologyRequires access

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome

Enrico Millefiorini, Claudio Gasperini, Carlo Pozzilli, Francesco D’Andrea, Alessandro Bozzao, A Calò, M. Bernini, D. Gambi, Massimiliano Prencipe, Stefano Bastianello, María Trojano, Vincenzo Brescia Morra, Stefania Morino

Open publisher page 271 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 271 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Mitoxantrone, Medicine, Multiple sclerosis, Expanded Disability Status Scale, Placebo, Neurology, Randomization, Clinical trial

Related papers

Back to paper searchBrowse research topicsOriginal source
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome — Research Paper | ScholarLens